USD10
IBIO Shares
About iBioiBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
USD10
IBIO Shares
About iBioiBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$68.76M
OPEN PRICE
$1.41
LOW (1Y)
$0.5562
HIGH (1Y)
$3.82
LOW (24H)
$1.34
HIGH (24H)
$1.47
VOLUME (24H)
$728.59K
72.49%
Price history
Time | Price | Change |
|---|---|---|
Today | $1.41 | |
1 Day | $1.40 | |
1 Week | $1.47 | |
1 Month | $1.76 | |
1 Year | $0.6333 |
Past performance is not a reliable indicator of future results.
Discover more
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.
